Learning Specialist, Padmaja Genesh, removes the guesswork and provides a monthly update on all of the noteworthy information regarding dementia. Below you'll find some highlights from recent months.
All of the updates are available to download on the right side of the screen.
Latest Highlights from April 2020
- Blood Pressure Treatment May Aid Cognition in Very Early Alzheimer’s
- Body mass index, diet, physical inactivity, and the incidence of dementia in 1 million UK women
- Decline in cognitive resources Influences physical activity after midlife.
- A perfect storm brewing for individuals and families impacted by dementia
- Individual Differences in the Effects of Physical Activity on Cognitive Function in People with Mild to Moderate Dementia
- Active Tau Vaccine: Hints of Slowing Neurodegeneration
- The Best Phospho-Tau Marker for Alzheimer’s Disease?
- In DIAN-TU, Gantenerumab Brings Down Tau. By a Lot. Open Extension Planned
- Aβ in Lewy Body Disease: Two Diseases at Once, or Another Beast Entirely?
Latest Highlights from March 2020
- Cognitive Difficulties Can Predict Neurodegeneration, Study Finds
- DNA from Bacteria in Brain May Promote Tau Clumping, Study Suggests
- Evidence on Cognitive Impairment Screening in Older Adults Is Insufficient, Panel Says
- Neurosteer Promotes Wearable Monitor to Detect Early Alzheimer’s
- PSEN1 Gene Alteration May Be Early Biomarker for Alzheimer’s, Study Suggests
- Stress-Related Disorders Are Associated with Increased Risk of Neurodegenerative Disease
- Blood Test Can Differentiate Alzheimer’s From Other Dementias, Research Suggests
- How and Why Living in Disadvantaged Communities Contributes to Neurodegeneration
Latest Highlights from February 2020
- Memory Health Awarded UK Patent as Alzheimer’s Treatment
- Inflammatory Conditions Linked to Higher Risk of Alzheimer’s
- Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals?
- FDA to Review Adlarity as Skin Patch Treatment for Alzheimer’s Dementia
- Dietary flavonols and risk of Alzheimer dementia
- Antipsychotics Are Associated with an Increased Risk for Traumatic Brain Injury in People with Alzheimer’s Disease
- Evidence on Cognitive Impairment Screening in Older Adults Is Insufficient, Panel Says
- Solanezumab and Gantenerumab Fail to Slow Memory Loss or Cognitive Decline in Early-onset Alzheimer’s, Study Finds
- Biogen to Start Re-dosing Aducanumab in Alzheimer’s Patients From Halted Trials
- New Carbon Nanotube Sensor Ably Spots Alzheimer’s via Proteins in Blood, Study Reports
Latest Highlights from January 2020
- Anti-Amyloid antibodies clear brain amyloid, would they improve cognition?
- Exercise and Brain Health Activities Are Associated with a Slower Rate of Frontotemporal Dementia (FTD)
- The Role that Fragmented Sleep Plays in Cognition
- Vascular Dysfunction Taxes Cognition, but Not Via Amyloid, AD
Visit our video library to learn more and see Padmaja discuss several hot topics.
Video: With so many media stories out there about dementia, it can be challenging to know who to trust.
Video: Most Common Research Questions